Company Filing History:
Years Active: 2011
Title: Innovations of Corinne Michaud in Cancer Research
Introduction
Corinne Michaud is an accomplished inventor based in Salem, MA (US). She has made significant contributions to the field of cancer research, particularly in the identification of novel phosphorylation sites that play a role in carcinoma and leukemia.
Latest Patents
Corinne Michaud holds one patent related to her groundbreaking work. The patent, titled "Tyrosine phosphorylation sites," discloses 482 novel phosphorylation sites identified in carcinoma and/or leukemia. It includes peptides, such as AQUA peptides, that comprise a phosphorylation site of the invention. Additionally, the patent covers antibodies that specifically bind to these novel phosphorylation sites, along with their diagnostic and therapeutic uses.
Career Highlights
Corinne Michaud is currently employed at Cell Signaling Technology, Inc., where she continues to advance her research in cancer biology. Her work has been instrumental in enhancing the understanding of phosphorylation sites and their implications in cancer treatment.
Collaborations
Corinne has collaborated with notable colleagues, including Peter Hornbeck and Ailan Guo, to further her research initiatives and expand the impact of her findings in the scientific community.
Conclusion
Corinne Michaud's innovative work in identifying novel phosphorylation sites has the potential to significantly influence cancer diagnostics and therapeutics. Her contributions exemplify the vital role of inventors in advancing medical science and improving patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.